Clearmind Medicine (NASDAQ:CMND) Announces Earnings Results

Clearmind Medicine (NASDAQ:CMND) posted its earnings results on Thursday. The company reported ($0.24) earnings per share (EPS) for the quarter, Zacks reports.

Clearmind Medicine Stock Up 0.9 %

NASDAQ CMND opened at $1.14 on Friday. The stock has a market cap of $4.86 million, a PE ratio of -0.61 and a beta of 1.02. Clearmind Medicine has a fifty-two week low of $0.95 and a fifty-two week high of $2.30. The business has a 50 day moving average price of $1.35 and a two-hundred day moving average price of $1.36. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.01.

About Clearmind Medicine

Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.